The Unified Biology of Fatigue: 3D Genomics Links ME/CFS, Long COVID, PTSD, MS & RA 🧬⚡

Inside EpiSwitch® Orion, 3D Genome Mapping & 4 Stunning Clues to Why Different Diseases May Converge

Inside Study 10.1186/s12967-026-08874-9 & 4 Stunning Conclusions

“The great paradox of chronic fatigue may be that different diseases don't need the same genes to disrupt the same biology. The genome can take different roads and still arrive at the same dysfunctional network.”

For decades, medicine has divided diseases into boxes.

A virus belongs over here.

An autoimmune disease over there.

Psychological trauma somewhere else entirely.

But what if dramatically different illnesses can travel through different biological roads—and eventually arrive at surprisingly similar cellular intersections?

That's the provocative possibility raised by a remarkable new study published in the Journal of Translational Medicine.

Researchers examined five seemingly disparate conditions:

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Long COVID. Post-Traumatic Stress Disorder (PTSD). Multiple sclerosis (MS). Rheumatoid arthritis RA).

Their initiating biology and clinical diagnoses differ considerably. Yet persistent fatigue, cognitive impairment, immune dysregulation and other overlapping symptoms can occur across them.

The researchers therefore asked a fascinating question:

What happens if, instead of merely looking at which genes are associated with each disease, we examine the biological networks those genes participate in—and the three-dimensional architecture regulating them?

That's where things got very interesting.

Because at the individual-gene level, overlap was surprisingly limited.

At the network level?

The diseases began talking to one another.

⚡ Quick Take / TL;DR

Researchers used EpiSwitch® 3D genomics, the Orion platform, genome-wide association study (GWAS) datasets and network-biology tools to compare ME/CFS, Long COVID, PTSD, rheumatoid arthritis and multiple sclerosis.

The individual disease-associated gene sets showed limited direct overlap.

But once researchers examined the higher-order networks connecting those genes, they found extensive biological convergence involving immune and cytokine signaling, interferon responses, mitochondrial/metabolic regulation and neuroendocrine processes. Candidate hubs included RUNX1, PPARGC1A, CDH2, NRP1 and PLCG2, while LAG3 emerged as an intriguing immune-regulatory node in the ME/CFS network.

That does not prove that these diseases are the same disease, that fatigue has one universal cause, or that scientists have discovered a treatment.

But it suggests something potentially profound:

Different diseases may disturb different genes while ultimately disrupting some of the same biological systems.

Welcome to biology in 3D.

Apparently DNA wasn't complicated enough already. 🧬😂

✅ FUNanc1al Atomic Statements

🗣️ Atomic Statement #1 — Different Genes, Same Neighborhood

“The great paradox of chronic fatigue may be that different diseases don't need the same genes to disrupt the same biology. The genome can take different roads and still arrive at the same dysfunctional network.” — FUNanc1al Bio-Performance & Health Desk

That, to me, is the central intellectual breakthrough of the paper.

🗣️ Atomic Statement #2 — Biology Is a Network, Not a Parts List

“A gene list tells us which biological players entered the stadium. Network biology begins telling us what game they're playing together. In complex disease, connectivity may reveal what isolated genes cannot.” — FUNanc1al

🗣️ Atomic Statement #3 — The End Is a New Beginning

“Perhaps this study's most exciting discovery isn't an answer but a new question: if apparently unrelated diseases converge when biology is examined in three dimensions, how many other connections are hiding inside genomic data we've already collected?” — FUNanc1al

And that's where this paper gets really fun.

🧬 What Does “3D Genomics” Actually Mean?

We tend to imagine DNA as a long sequence of letters.

A gigantic biological instruction manual:

A...C...G...T...

Except DNA doesn't sit neatly stretched out inside your cells.

It folds.

A lot.

The human genome is organized in three-dimensional space inside the nucleus, bringing genomic regions that may be far apart along the linear DNA sequence into physical proximity. Those interactions can influence gene regulation. The EpiSwitch platform analyzes chromosome-conformation signatures designed to capture some of this spatial regulatory architecture.

Think of conventional sequencing as reading the addresses in a city directory.

3D genomics asks:

Who is actually visiting whom?

Or, in slightly more FUNanc1al terms:

Scientists spent decades reading the instruction manual.

Then somebody noticed the manual had been folded into origami. 🦢

🔬 What the Researchers Actually Did

The researchers combined previously characterized EpiSwitch ME/CFS biomarker data with GWAS-derived information across the five conditions and used Orion to generate disease-specific 3D genomic anchors.

The resulting datasets included:

• ME/CFS: 552 anchors → 567 genes
• Long COVID: 611 → 567 genes
• PTSD: 362 → 324 genes
• MS: 730 → 629 genes
• RA: 965 → 885 genes

They then examined how the resulting proteins and pathways interacted using tools including STRING and Cytoscape.

And here came the surprise.

Direct gene overlap was small.

Yet when those disease-specific networks were merged, researchers found extensive interconnections—a continuous multi-disease interaction landscape.

In other words:

The ingredients differed considerably.

The biological recipes overlapped.

🔋 The Shared Biological Neighborhoods

Several major themes emerged.

1. Immune Regulation & Inflammation

Cytokine signaling, interferon pathways, antigen presentation and immune regulation repeatedly appeared.

STAT1 and HLA-DQA2 emerged as important network hubs, while LAG3 appeared as an intriguing ME/CFS-associated candidate node. Because LAG3 is involved in immune-checkpoint regulation and T-cell exhaustion, researchers suggest it may help connect chronic immune activation with altered T-cell responses.

But importantly: LAG3 is a candidate, not a proven causal mechanism or validated drug target for ME/CFS.

That's an important distinction.

2. Energy & Mitochondrial Biology

The networks also highlighted mitochondrial biogenesis, glycolysis, fatty-acid metabolism and other energy-regulation pathways.

Particularly interesting was PPARGC1A, which encodes PGC-1α, an important regulator of mitochondrial biogenesis.

That provides a plausible biological bridge between network dysfunction and something patients actually experience:

profound loss of energy.

The battery metaphor isn't completely ridiculous after all.

🔋 Low Power Mode: involuntary.

3. Neuroendocrine & Stress Biology

PTSD adds another fascinating dimension.

Its genes didn't simply form some completely isolated “psychological” island. They were embedded within interconnected networks involving ME/CFS and Long COVID.

The researchers point particularly to glucocorticoid-receptor signaling and other stress-response networks as possible bridges connecting chronic stress, immune regulation and systemic biology.

That doesn't mean psychological trauma and viral infection are biologically identical.

They aren't.

It means that very different initiating insults may ultimately perturb some overlapping regulatory systems.

And that distinction matters enormously.

🌟 Four Stunning Conclusions

1. Different Diseases Can Converge Without Sharing the Same Genes

This may be the paper's biggest conceptual contribution.

Medicine understandably spends enormous effort looking for common genes.

But complex diseases may resemble one another not because they possess identical genetic abnormalities, but because different genetic inputs disturb interconnected biological networks that perform similar functions.

That's a very different way of thinking about disease.

And potentially a much more powerful one.

2. “Physical” Versus “Psychological” May Be Far Too Primitive a Biological Divide

PTSD isn't being declared equivalent to Long COVID or ME/CFS.

But finding PTSD-associated genes embedded within overlapping immune, neuroendocrine and metabolic networks is another reminder that the traditional wall between mind and body is biologically porous.

Stress changes biology.

Infection changes biology.

Autoimmune disease changes biology.

The initiating events differ.

Some downstream systems may intersect.

The body apparently never received medicine's departmental organizational chart.

3. Shared Networks Could Eventually Mean Shared Diagnostic or Therapeutic Opportunities

If several diseases repeatedly converge on common regulatory hubs, researchers can ask whether those hubs offer:

better biomarkers;

better patient stratification;

new therapeutic targets;

or even opportunities to repurpose treatments across diseases.

The authors specifically see potential for objective blood-based diagnostics and cross-disease therapeutic investigation.

But this is where enthusiasm requires discipline.

The candidate hub genes identified in this study have not been independently validated as causal drivers, and therapeutic benefit remains unproven. The authors explicitly call for functional experiments, independent cohorts and clinical trials.

So:

Road map? Possibly.

Cure? Absolutely not yet.

4. Perhaps the Biggest Discovery Is Everything We Haven't Discovered Yet

This may be my favorite implication.

Scientists already possess enormous repositories of genomic information.

Historically, much of that information has been interrogated through relatively linear relationships:

variant → gene → disease.

But biology isn't linear.

It's spatial, dynamic, interconnected and contextual.

If 3D genomic and network approaches can extract relationships from existing datasets that weren't obvious before, the potential extends far beyond fatigue-associated disorders.

Cancer.

Neurodegeneration.

Autoimmunity.

Metabolic disease.

Psychiatric illness.

Aging.

Rare diseases.

Perhaps enormous amounts of biological information are already sitting in databases waiting for somebody to ask a better question.

The end is a new beginning.

The 9-Region Pain Map: How to Pinpoint Your Abdominal Pain Like a Pro

⚠️ Now for the Scientific Brakes

The researchers themselves identify significant limitations.

The five disease datasets differed in cohort composition, sample size, ancestry and phenotype definitions. The study did not perform formal permutation-based statistical validation of network convergence against a random null model. The candidate hub genes require independent experimental validation. Longitudinal work is needed to determine how stable the 3D signatures remain over time.

And there's one particularly important limitation:

This was a disease-centric analysis, not a fatigue-centric analysis.

The researchers did not assemble people across all five diseases and directly stratify them by fatigue severity using harmonized measurements.

Consequently, they explicitly say the shared network biology cannot yet be attributed specifically to fatigue; some of the convergence could instead reflect broader inflammation, immune activation or metabolic dysregulation.

That's why I would avoid the phrase “Grand Unified Theory of Biological Fatigue” as a factual description.

But as an editorial question?

Absolutely:

Are we beginning to glimpse a unified network biology behind some forms of chronic exhaustion?

Now that's defensible—and fascinating.

🧪 One More Remarkable Number: 96%

There is another eye-catching result associated with this research program, but it needs careful attribution.

A previously published EpiSwitch ME/CFS study developed a 200-marker chromosome-conformation classifier. In an independent validation cohort of 24 ME/CFS cases and 45 controls, it achieved 92% sensitivity, 98% specificity and 96% overall accuracy.

That's impressive.

But the current five-disease network analysis did not independently validate those diagnostic results.

The authors explicitly separate the two findings.

That nuance is worth preserving because the eventual promise is enormous:

moving conditions such as ME/CFS from predominantly symptom-based diagnosis toward objective biological measurement.

🎭 A Little Genomic Humor

The Biological Battery:
Maybe mitochondria really are the body's batteries. Unfortunately, there's still no USB-C port. 🔋

The Origami Problem:
We spent decades reading DNA as a sequence only to discover that biology had folded the instruction manual into a paper crane.

The Medical Filing Cabinet:
Medicine put Long COVID, PTSD, MS, RA and ME/CFS into different drawers.

Biology apparently forgot to respect the filing system.

💭 Food for Thought: The Cross-Hub Connection

There's a wonderful FUNanc1al connection here to investing, AI—and even how we think.

Great investors don't merely ask:

Which companies own the same assets?

They ask:

Which companies participate in the same economic system?

AI increasingly works similarly: intelligence emerges not merely from isolated pieces of information but from relationships among them.

And biology may be telling us something analogous.

Sometimes the signal isn't in the individual nodes.

It's in the network connecting them.

Genes. Companies. Neurons. People.

Different systems.

Same lesson:

Connections can contain information that components alone cannot reveal.

📌 Signal Extract

“The great paradox of chronic fatigue may be that different diseases don't need the same genes to disrupt the same biology. The genome can take different roads and still arrive at the same dysfunctional network.” — FUNanc1al Bio-Performance & Health Desk

🎯 High-Conviction Takeaway

“A gene list tells us which biological players entered the stadium. Network biology begins telling us what game they're playing together. In complex disease, connectivity may reveal what isolated genes cannot.” — FUNanc1al

❤️ FunHealth Index™: 9.2 / 10 🔥

Why so high?

➕ A genuinely novel systems-level perspective across five complex diseases
➕ Striking contrast between low gene overlap and high network interconnectivity
➕ Connects immune, metabolic, mitochondrial and neuroendocrine biology
➕ Generates intriguing candidate hubs and potential diagnostic/therapeutic directions
➕ Opens an enormous runway for further 3D-genomics research
➖ Network findings remain hypothesis-generating rather than causal or therapeutic proof
➖ The study cannot yet establish that the shared biology is specifically the biology of fatigue

❓ FAQ

What did the study discover?

It found that ME/CFS, Long COVID, PTSD, MS and RA have relatively little direct overlap among their associated genes but show extensive convergence when those genes are examined as interconnected biological networks.

Does this prove all five diseases have the same cause?

No. Their causes, manifestations and biology remain distinct. The finding is that different disease-associated genetic signals can converge on overlapping biological systems.

Does the study prove fatigue has one biological cause?

No. The researchers specifically caution that their analysis was organized around diseases rather than fatigue severity, so the shared network architecture cannot yet be attributed specifically to fatigue.

What is EpiSwitch® Orion?

It is an analytical platform that uses genomic variation and 3D chromatin architecture to identify regulatory anchors and investigate how genetic variation may influence genomic folding and biological networks.

Did researchers discover a treatment?

No. They identified candidate pathways and hub genes that warrant further investigation. Functional validation, independent replication and ultimately clinical studies would be necessary before therapeutic claims could be made.

Why does the study matter?

Because it demonstrates how diseases that look quite different genetically can become related when viewed at the level of biological networks—potentially providing new ways to investigate biomarkers, disease mechanisms and therapeutic targets.

🌅 The End Is a New Beginning

Perhaps that's the most beautiful part of this study.

It doesn't finish the story.

It changes where we look for the next chapter.

The old question was:

Which gene causes this disease?

The emerging question may increasingly become:

Which networks have been disrupted, how are they regulated in three-dimensional space—and can we restore them?

That's a much bigger question.

And this investigation suggests that genomic databases accumulated over decades may still contain relationships we simply haven't learned how to see.

Sometimes scientific progress comes from discovering new data.

Sometimes it comes from looking at old data in an entirely new dimension.

The genome didn't suddenly become three-dimensional.

Our understanding did.

Carpe Diem. 🧬⚡

👤 About the Author

Frédéric Marsanne is the founder of FUNanc1al—part market analyst, part storyteller, part accidental comedian. A longtime investor, entrepreneur, and venture-builder across tech, biotech, and fintech, he now blends rigorous financial analysis with a twist of humor to help readers laugh, learn, live healthier lives, and invest a little wiser.

His research focuses on insider buying, hedge funds, valuation, behavioral finance, long-term wealth creation, and the fascinating intersections between business, science, technology, health, passions, and everyday life.

When not decoding SEC filings or poking fun at earnings calls, he's building Cl1Q, writing fiction, painting, creating videos, or discovering new passions to FUNalize.

📝 Editorial Note

Every FUNanc1al article is grounded in human research, analysis, and editorial judgment. Modern AI tools may assist with research organization, editing, and presentation, but every opinion, conclusion, rating, and editorial judgment remains subject to human oversight and responsibility.

To learn more about how we research, write, and review every article, please visit our Editorial Process page.

The present article is almost tailor-made for our FUNanc1al Health hub: genuinely new science, counterintuitive finding, enormous future implications, understandable visual metaphor, and enough uncertainty that we can distinguish FUNanc1al from sensationalized health coverage by being excited without pretending hypothesis-generating science is settled medicine.